Minneapolis, March, 17 2010 — Vertebral Technologies, Inc. (VTI), a Minnetonka, MN based spinal implant manufacturer announced a major milestone in the commercialization of the InterFuse® Interbody Fusion Device. On March 3rd, the 600th InterFuse Device was implanted using VTI’s patented Intraoperative Assembly™ technology, which allows the surgeon to assemble a large implant through a minimally invasive surgical approach. The Unilateral Posterior Lumbar Interbody Fusion (UPLIF®) procedure uses a single posterior incision to access the disc, reducing tissue dissection and nerve root retraction while preserving the facet joints. VTI continues to expand commercial distribution of the InterFuse Interbody Fusion System throughout the United States.
Ali Araghi, D.O., of the Texas Back Institute in Phoenix, AZ said, “The InterFuse Interbody Fusion System is a great addition to my treatment armamentarium. The system allows me to deliver a large foot print through a small unilateral posterior approach affording my patients a very stable interbody construct. My experience suggests that the patients that receive the interfuse technology should have better fusion rates with the enhanced footprint than the traditional interbody devices. We obviously need further data”
Jeffrey Felt, M.D., Chief Executive Officer of VTI, comments, “We are very pleased with the rapid adoption of the Interfuse Interbody Fusion System. Our initial six month imaging data shows a very high rate of fusion and validates our Intraoperative Assembly approach for implanting large devices through minimal access surgery. VTI continues to develop this concept for other surgical approaches for fusion and for motion preserving devices, such as the InterCushion® Disc Nucleus Replacement Device.”
About Vertebral Technologies, Inc.
Vertebral Technologies has pioneered Intraoperative Assembly technology which enables spine surgeons to implant large, customized devices in the intervertebral disc space. This technology platform is being adapted for a number of spinal implant applications. The Company’s first two products are the InterFuse Interbody Fusion System, which has been available for sale in the U.S. since 2008 and the InterCushion® Disc Nucleus Replacement, which will begin human clinical testing in 2010